Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
167,527,305
-
Shares change
-
-917,064
-
Total reported value, excl. options
-
$3,008,326,722
-
Value change
-
-$15,294,872
-
Put/Call ratio
-
30.09%
-
Number of buys
-
96
-
Number of sells
-
-102
-
Price
-
$17.96
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q3 2021
279 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 167,527,305 shares
.
Largest 10 shareholders include Invesco Ltd. (35,671,187 shares), BlackRock Inc. (18,844,244 shares), PRIMECAP MANAGEMENT CO/CA/ (17,979,522 shares), VANGUARD GROUP INC (17,108,265 shares), FMR LLC (14,007,744 shares), WELLINGTON MANAGEMENT GROUP LLP (11,383,721 shares), MAVERICK CAPITAL LTD (5,838,426 shares), STATE STREET CORP (4,649,113 shares), Bellevue Group AG (4,594,656 shares), and FIRST TRUST ADVISORS LP (3,796,316 shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.